NeuroSense Therapeutics Ltd. Reclassification Adjustments On Exchange Differences On Translation Net Of Tax
NeuroSense Therapeutics Ltd. (NRSN) reported Reclassification Adjustments On Exchange Differences On Translation Net Of Tax of $4.23 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax · last filed 2024-04-04
| Period end | Reclassification Adjustments On Exchange Differences On Translation Net Of Tax 12 month |
|---|---|
| 2023-12-31 | $4.23M 20-F · filed 2024-04-04 |
| 2022-12-31 | $1.26M 20-F · filed 2024-04-04 |
| 2021-12-31 | $2.73M 20-F · filed 2024-04-04 |
| 2020-12-31 | $61.00K 20-F · filed 2023-03-22 |
| 2019-12-31 | $18.00K 20-F · filed 2022-04-14 |